Market Study on Personal Accident, Reinsurance and Health Insurance Industry in Chile, 2018

ResearchMoz.us include new market research report " Personal Accident, Reinsurance and Health Insurance Market in Chile, 2018: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

Personal Accident and Health Insurance in Chile:-

The personal accident and health insurance segment was one of the fastest-growing in the Chilean insurance industry during the review period (2009–2013). The segment primarily benefited from the country’s increasing healthcare cost, compulsory personal accident insurance, compulsory minimum health insurance contributions and growth within the travel and tourism sector.

View Full Report with TOC at: http://www.researchmoz.us/personal-accident-and-health-insurance-in-chile-key-trends-and-opportunities-to-2018-report.html

The leading insurers in the segment included MetLife Chile, EuroAmerica and BICE Vida. The segment’s healthy review-period growth is expected to encourage several international companies to enter the segment, making it more competitive over the forecast period (2013−2018). Moreover, government efforts to build a regulatory framework for private health insurers, along with country’s regulatory reforms in line with Europe’s solvency regulations, are projected to support Chilean personal accident and health insurers to build high levels of consumer confidence.

Reinsurance in Chile:-

Reinsurance plays a major role in the Chilean insurance industry, especially for catastrophe exposure, as domestic insurers do not generally have the capital to mitigate these risks. The Chilean reinsurance segment is open to foreign insurers, as there is a negligible number of locally established reinsurers in the country. Non-life insurers cede the largest proportion of premium to reinsurers, while facultative reinsurance was the leading reinsurance category, contributing 60.1% of the segment’s gross written premium in 2013.

View Full Report with TOC at:...